Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs. | Neuroradiology;66(4): 461-462, 2024 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Reply: assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs.

Guerrero-Molina, María Paz; González de la Aleja, Jesús.

Affiliation

Guerrero-Molina MP; Neurology Department, Neuromuscular Disorders Unit, University Hospital, 12 de Octubre, Madrid, Spain. maripazguerrero@gmail.com.
González de la Aleja J; Neurology Department, Epilepsy Unit, University Hospital, 12 de Octubre, Madrid, Spain.

Neuroradiology ; 66(4): 461-462, 2024 Apr.

Article in En | MEDLINE | ID: mdl-38311630

Subject(s)

MELAS Syndrome; Humans; MELAS Syndrome/genetics; Glutamine/genetics; Phenotype

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MELAS Syndrome Limits: Humans Language: En Journal: Neuroradiology Year: 2024 Document type: Article Affiliation country: Spain

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MELAS Syndrome Limits: Humans Language: En Journal: Neuroradiology Year: 2024 Document type: Article Affiliation country: Spain